264 results on '"Ngo, Hai T."'
Search Results
2. Editor's Note: Eph-B2/Ephrin-B2 Interaction Plays a Major Role in the Adhesion and Proliferation of Waldenstrom's Macroglobulinemia
3. Internationalization of Firms and Entrepreneur’s Motivations: A Review and Research Agenda
4. Supplementary Figures S1-S3 from Carfilzomib-Dependent Selective Inhibition of the Chymotrypsin-like Activity of the Proteasome Leads to Antitumor Activity in Waldenstrom's Macroglobulinemia
5. Supplementary Data from Src Tyrosine Kinase Regulates Adhesion and Chemotaxis in Waldenstrom Macroglobulinemia
6. Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
7. P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment
8. Key Role of MicroRNAs in Waldenström's Macroglobulinemia Pathogenesis
9. microRNA-dependent modulation of histone acetylation in Waldenström macroglobulinemia
10. Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenström macroglobulinemia
11. Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia
12. RhoA and Rac1 GTPases play major and differential roles in stromal cell–derived factor-1–induced cell adhesion and chemotaxis in multiple myeloma
13. MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
14. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
15. microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia
16. Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia
17. SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia
18. Targeting NF-κB in Waldenstrom macroglobulinemia
19. Dual targeting of the proteasome regulates survival and homing in Waldenström macroglobulinemia
20. FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins
21. The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia
22. Novel Agents in the Treatment of Waldenströmʼs Macroglobulinemia
23. Correction: Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenström Macroglobulinemia
24. Hypoxia promotes dissemination of multiple myeloma through acquisition of endothelial to mesenchymal transition-like features
25. Eph-B2/Ephrin-B2 Interaction Plays a Major Role in the Adhesion and Proliferation of Waldenstrom's Macroglobulinemia
26. Deregulation of TNFRSF18 (GITR) Through Promoter CpG Island Methylation Induces Tumor Proliferation in Multiple Myeloma
27. The New CXCR4 Inhibitor MDX-1338 Exerts Anti-Tumor Activity in Multiple Myeloma
28. L-Stereoisomer RNA Oligonucleotide Anti-SDF-1 (Nox-A12) Disrupts the Interaction of Multiple Myeloma Cells with the Bone Marrow Milieu In Vivo, Leading to Enhanced Sensitivity to Bortezomib
29. LNA Anti-MicroRNA-155: A Novel Therapeutic Strategy in Waldenstrom Macroglobulinemia and Chronic Lymphocytic Leukemia
30. The Role of PI3K Signaling in Cell Trafficking of Multiple Myeloma
31. Stroma-Derived Exosomes Mediate Oncogenesis in Multiple Myeloma
32. Role of TORC1 and TORC2 in Multiple Myeloma
33. Dissecting the role of CXCR7 in Cell Trafficking of Endothelial-Cells and Endothelial-Progenitor-Cells in Multiple Myeloma,
34. Hypoxia Promotes Dissemination of Multiple Myeloma Through Acquisition of Endothelial to Mesenchymal Transition (EMT) Features
35. MicroRNA-155 As a Potential Plasma Biomarker for Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia,
36. FGFR3 Is Overexpressed Waldenström Macroglobulinemia and Its Inhibition by Dovitinib Induces Apoptosis and Overcomes Stroma-Induced Proliferation
37. Carfilzomib-Dependent Selective Inhibition of the Chymotrypsin-like Activity of the Proteasome Leads to Antitumor Activity in Waldenstrom's Macroglobulinemia
38. Promoter-Wide Transcriptional Deregulation In Waldenstrom Macroglobulinemia
39. LNA Anti-Microrna-155: a Novel Therapeutic Strategy In Waldenstrom Macroglobulinemia and Chronic Lymphocytic Leukemia
40. Dynamic Regulation of the Level of Hypoxia In the Bone Marrow Regulates Cell Dissemination In Multiple Myeloma
41. Proteomic Studies Identify Citron Rho Interacting Kinase (CRIK), a Novel Protein That Regulates Proliferation and Survival In Multiple Myeloma Cells
42. Eph-B2/Ephrin-B2 Interaction Plays a Major Role In the Adhesion and Survival of WM Cells In the Context of the Bone Marrow Microenvironment
43. Genome Wide DNA Methylation Profiling In Patients with Multiple Myeloma.
44. Dual Targeting of -TORC1 and -TORC2 as a New Strategy In the Treatment of Multiple Myeloma
45. Selectin Inhibition Disrupts Multiple Myeloma Cells Interaction with the Bone Marrow Microenvironment and Sensitizes Them to Therapy
46. Abstract 2060: microRNA-dependent modulation of histone acetylation in Waldenstrom's Macroglobulinemia
47. Role of Selectins in the Pathogenesis of Multiple Myeloma.
48. Eph-B2 Receptor Tyrosine Kinase Is Overexpressed in Waldenstrom's Macroglubulinemia and Plays a Major Role in Its Interaction with the Bone Marrow Microenvironment.
49. Citron Rho Interacting Kinase (CRIK) Regulates Survival in IL-6 Dependent Multiple Myeloma Cells.
50. Role of Hypoxia in the Progression and Dissemination of Multiple Myeloma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.